- Home
- BHC vs XPRO Comparison
BHC vs XPRO Comparison
Compare BHC & XPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHC | XPRO |
|---|---|---|
| Founded | N/A | 1938 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oilfield Services/Equipment |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 1996 | 2026 |
Fundamental Metrics
Financial Performance| Metric | BHC | XPRO |
|---|---|---|
| Price | $6.21 | $18.41 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 5 |
| Target Price | $8.00 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 4.8M | 982.2K |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 423.08 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,724,000,000.00 | N/A |
| Revenue This Year | $4.61 | $1.86 |
| Revenue Next Year | N/A | $4.70 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.33 | $10.18 |
| 52 Week High | $8.69 | $18.73 |
Technical Indicators
Market Signals| Indicator | BHC | XPRO |
|---|---|---|
| Relative Strength Index (RSI) | 61.34 | 69.91 |
| Support Level | $5.42 | $15.14 |
| Resistance Level | $7.34 | $18.59 |
| Average True Range (ATR) | 0.44 | 0.90 |
| MACD | 0.08 | 0.27 |
| Stochastic Oscillator | 63.32 | 98.42 |
Price Performance
Historical ComparisonAbout BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.
About XPRO Expro Group Holdings N.V.
Expro Group Holdings NV offers products and services that span the well life cycle, including well construction, well flow management, well intervention and integrity, and subsea well access. It maintains operations around the world and specializes in offshore production solutions. It also provides production optimization for both onshore and offshore applications. The company has four operating segments: North and Latin America (NLA); Europe and Sub-Saharan Africa (ESSA); Middle East and North Africa (MENA); and Asia-Pacific (APAC). The majority of its revenue is derived from the North and Latin America (NLA) segment.